InstaPILL

Bengaluru, India· Est. 2020

A leading Indian CDMO specializing in proprietary lyophilized orally disintegrating tablet technology for patient-centric drug delivery.

insta-pill.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

A leading Indian CDMO specializing in proprietary lyophilized orally disintegrating tablet technology for patient-centric drug delivery.

Central Nervous SystemGastroenterologyAllergy & ImmunologyPsychiatry

Technology Platform

Proprietary lyophilization (freeze-drying) technology platform for manufacturing porous, rapidly dissolving Orally Disintegrating Tablets (ODTs) that disintegrate in 3-10 seconds without water.

Opportunities

Growing global demand for patient-centric dosage forms to improve medication adherence in pediatric, geriatric, and dysphagic populations, and the trend for pharma companies to outsource complex formulation development to specialized CDMOs.

Risk Factors

Dependence on the pharmaceutical outsourcing market, concentration risk in a single technology platform (lyophilized ODTs), and intense competition from other CDMOs and large pharma with internal capabilities.

Competitive Landscape

Competes with other ODT-focused CDMOs (e.g., companies like Aprecia, Catalent's Zydis platform) and large pharma's internal units. Differentiation lies in its high-capacity, automated lyophilization facility, extensive taste-masking expertise, and regulatory approvals for all major markets.

More companies in India →